Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological ignorance of solid tumors.

Adrian F Ochsenbein1

  • 1Department of Clinical Research, University of Berne, Murtenstrasse 35, 3010, Berne, Switzerland. adrian.ochsenbein@insel.ch

Springer Seminars in Immunopathology
|June 21, 2005
PubMed
Summary

Solid tumors like carcinomas and sarcomas are often ignored by the immune system due to inefficient surveillance. Vaccination strategies can leverage this to induce T cell immunity against tumor antigens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

Leukemia·2026
Same author

Intestinal low-abundant bacteria drive MyD88/Trif-dependent CD8<sup>+</sup> T cell exhaustion in chronic myeloid leukemia.

Cell reports·2025
Same author

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Nature communications·2025
Same author

IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and aging.

iScience·2025
Same author

Immune checkpoints regulate acute myeloid leukemia stem cells.

Leukemia·2025
Same author

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

Cell reports. Medicine·2024

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Solid tumors, including sarcomas and carcinomas, express tumor-specific antigens targeted by T cells.
  • Immune surveillance against established carcinomas and sarcomas is often inefficient.
  • T cell activation occurs in secondary lymphoid organs, with priming dependent on antigen-presenting cells or tumor cell migration.

Purpose of the Study:

  • To investigate the reasons for inefficient immune surveillance against solid tumors.
  • To explore the potential of vaccination for inducing anti-tumor T cell immunity.

Main Methods:

  • The study discusses mechanisms of T cell activation and immune evasion in the context of solid tumors.
  • It analyzes the limitations of natural immune responses, including cross-priming by professional antigen-presenting cells (pAPC) and direct tumor cell presentation.

Main Results:

  • Direct T cell priming is inefficient in early tumor development due to limited metastasis.
  • Cross-priming by pAPC is often limited by antigen availability and dendritic cell maturation stimuli.
  • Solid tumors may evade immune detection for prolonged periods.

Conclusions:

  • Inefficient immunosurveillance suggests that solid tumors are initially ignored by the immune system.
  • This 'ignored' state presents an opportunity for therapeutic vaccination to induce T cell immunity.
  • Vaccination can be effective as the T cell repertoire is still naive and not subject to tolerance mechanisms.

Related Experiment Videos